Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus

References

• Svoren BM Jospe N Diabetes mellitus in children Kliegman RM Stanton BF St Geme JW Score NF Behrman RE Nelson’s Textbook of Pediatrics 20th ed. Elsevier, Inc Chapter 589 2016 2760 2782
   Google Scholar
• American Diabetes Association (ADA) Diagnosis and classification of diabetes mellitus Diabetes Care 2013 35 1 64 71
   Web of Science ®Google Scholar
• Kher K Mietus-Snyder M Kidney disease associated with diabetes mellitus and metabolic syndrome Kher KK Schnaper HW Greenbaum LA Clinical Pediatric and Nephrology 3rd ed Boca Raton, FL CRC Press 2017 Part E 533 540
   Google Scholar
• Kolset SO Reinholt FP Jenssen T Diabetic nephropathy and extracellular matrix J Histochem Cytochem 2012 60 12 976 986 23103723
   PubMed Web of Science ®Google Scholar
• Demirel F Tepe D Kara O Esen I Microvascular complications in adolescents with type 1 diabetes mellitus J Clin Res Pediatr Endocrinol 2013 5 3 145 149 24072081
   PubMed Web of Science ®Google Scholar
• Li Y Shi B Li S Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis PLoS One 2014 9 12 e113915 25469985
   PubMed Web of Science ®Google Scholar
• Huang Z Wu L Chen L Apelin/APJ system: a novel potential therapy target for kidney disease J Cell Physiol 2018 233 5 3892 3900 28796300
   PubMed Web of Science ®Google Scholar
• Flegg HM Ames Award Lecture 1972. An investigation of the determination of serum cholesterol by an enzymatic method Ann Clin Biochem 1973 10 1–6 79 84
   Google Scholar
• Mogensen CE Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes N Engl J Med 1984 310 6 356 360 6690964
   PubMed Web of Science ®Google Scholar
• Takahashi M Takahashi Y Takahashi K Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes FEBS Lett 2008 582 5 573 578 18242188
   PubMed Web of Science ®Google Scholar
• Burtis CA Ashwood ER Tietz Textbook of Clinical Chemistry 2nd ed. Philadelphia WB Saunders 1994 1017 1089
   Google Scholar
• Kaliora AC Kanellos PT Gioxari A Karathanos VT Regulation of GIP and ghrelin in healthy subjects fed on sun-dried raisins: a pilot study with a crossover trial design J Med Food 2017 20 3 301 308 28170279
   PubMed Web of Science ®Google Scholar
• Vehapoglu A Ustabas F Ozgen TI Terzioglu S Cermik BB Ozen OF Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial J Pediatr Endocrinol Metab 2015 28 9–10 1065 1071 25915077
   PubMed Web of Science ®Google Scholar
• Khaled Y Rashed L Serum chemerin levels and chemerin rs17173608 genotypes in the susceptibility of diabetic nephropathy in Egyptian diabetic patients Egypt J Obes Diabetes Endocrinol 2016 2 1 18 22
   Google Scholar
• El-Gohary IE Abedl-Karima Hashad DI Serum chemerin level: does it have a role in progression of diabetic nephropathy Am J Intern Med 2016 4 2–1 13 17
   Google Scholar
• El Dayem SMA Battah AA El Bohy AEM El Shehaby A El Ghaffar EA Relationship of plasma level of chemerin and vaspin to early atherosclerotic changes and cardiac autonomic neuropathy in adolescent type 1 diabetic patients J Pediatr Endocrinol Metab 2015 28 3–4 265 273 25210758
   PubMed Web of Science ®Google Scholar
• Dayem SMAE Battah AA Bohy AEME Yousef RN Ahmed AM Talaat AA Apelin, nitric oxide and vascular affection in adolescent type 1 diabetic patients Open Access Maced J Med Sci 2017 5 7 934 939 29362622
   PubMedGoogle Scholar
• Meral C Tascilar E Karademir F Elevated plasma levels of apelin in children with type 1 diabetes mellitus J Pediatr Endocrinol Metab 2010 23 5 497 502 20662349
   PubMed Web of Science ®Google Scholar
• Habchi M Duvillard L Cottet V Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control Clin Endocrinol 2014 81 5 696 701
   PubMed Web of Science ®Google Scholar
• Al-Suhaimi EA Al-Kulaifi FM Ravinayagam V Al-Qahtani MH Serum adipocytokines, metabolic and immunological correlations in type 1 diabetes mellitus (T1DM) children Open Endocrinol J 2012 6 1 110 116
   Google Scholar
• Nascimento AMMAD Sequeira IJ Vasconcelos DF Gandolfi L Pratesi R Nóbrega YKM Endothelial dysfunction in children with type 1 diabetes mellitus Arch Endocrinol Metab 2017 61 5 476 483 28658349
   PubMed Web of Science ®Google Scholar
• Yue P Jin H Xu S Apelin decreases lipolysis via G(q), G(i), and AMPK-dependent mechanisms Endocrinology 2011 152 1 59 68 21047945
   PubMed Web of Science ®Google Scholar
• Than A Cheng Y Foh L-C Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways Mol Cell Endocrinol 2012 362 1–2 227 241 22842084
   PubMed Web of Science ®Google Scholar
• Yue P Jin H Aillaud M Apelin is necessary for the maintenance of insulin sensitivity Am J Physiol Endocrinol Metab 2010 298 1 E59 E67 19861585
   PubMed Web of Science ®Google Scholar
• Soriguer F Garrido-Sanchez L Garcia-Serrano S Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus Obes Surg 2009 19 11 1574 1580 19756893
   PubMed Web of Science ®Google Scholar
• Weigert J Neumeier M Wanninger J Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes Clin Endocrinol 2010 72 3 342 348
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Position Statement: Standards of Medical Care in Diabetes –2015 Diabetes Care 2015 38 Suppl. 1 S1 S94
   PubMed Web of Science ®Google Scholar
• Kidoya H Ueno M Yamada Y Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis Embo J 2008 27 3 522 534 18200044
   PubMed Web of Science ®Google Scholar
• Bozaoglu K Curran JE Stocker CJ Chemerin, a novel adipokine in the regulation of angiogenesis J Clin Endocrinol Metab 2010 95 5 2476 2485 20237162
   PubMed Web of Science ®Google Scholar
• Navarro-González JF Mora-Fernández C The role of inflammatory cytokines in diabetic nephropathy J Am Soc Nephrol 2008 19 3 433 442 18256353
   PubMed Web of Science ®Google Scholar
• Guo C Liu Y Zhao W Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities J Cell Mol Med 2015 19 9 2273 2285 26103809
   PubMed Web of Science ®Google Scholar
• Dawood A Abdelraof M El Ghobashy Y The relationship between serum apelin level and different grades of diabetic nephropathy in type 2 diabetic patients Egypt J Obes Diabetes Endocrinol 2017 3 1 32 37
   Google Scholar